DIN 02554267 — BRUKINSA 160 MG
BRUKINSA is a tablet of Zanubrutinib marketed by BEONE MEDICINES I GMBH. The full Zanubrutinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02554267
- Brand name
- BRUKINSA
- Active ingredient
- Zanubrutinib
- Strength
- 160 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- BEONE MEDICINES I GMBH
- Health Canada status
- MARKETED
- Drug class
- Bruton's tyrosine kinase (BTK) inhibitor (antineoplastic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Zanubrutinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02512963 | BRUKINSA | 80 MG | CAPSULE | BEONE MEDICINES I GMBH | MARKETED |